Abstract
Osteonecrosis of the jaw (ONJ) is a complication associated with the use of bisphosphonates (BPs) in patients with multiple mieloma (MM). It is known that the previous dental procedures can precipitate the development of ONJ, but other risk factors remain unexplored. Recently, has been described the implication of other drugs in ONJ, mainly antiangiogenic treatments, but their study in the context of MM has not been performed. Objective To study the characteristics and risk factors currently implicated in the development of ONJ in patients with symptomatic MM in 13 Spanish hospitals in the last 10 years.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
